Length of Stay Reduction at Glendale Adventist Medical Center

MicrobloggingMD Discharge

Our second post features another excerpt from our interview with Romic Eskandarian, Pharm. D., Director of Pharmaceutical Services at Glendale Adventist Medical Center, discussing the reason he looked at MicroBloggingMD to help improve outcomes and the results his team is achieving.

MicrobloggingMD:

Have you experienced the results you were looking for with MicroBloggingMD? If so, please explain.

Romic Eskandarian:

Yes. MicroBloggingMD has been able to meet our expectations. Mb has provided the grand work of obtaining clinical data in many daily clinical pharmacy activities.

The intensive glycemic project is ongoing and demonstrating impressive results. Since the introduction of the Basal-bolus project, we’ve seen an 11 point reduction in POC glucose for the entire patient population. Patients on the protocol exhibit significant reduction in average glucose following the initiation of the intervention versus similarly hyperglycemic patients without intervention. Preliminary estimates indicate that the target hyperglycemic population length of stay (LOS) has been reduced by .14 days per patient.

Check back next week for the concluding post, and if you’d like to learn more about how MicrobloggingMD can help you reduce length of stay, please contact us at: MicroBloggingMD.info@m2is.com.

Leave a Reply